pH-responsive ZIF-8-based nitazoxanide nanodelivery system for synergistic inhibition of retinoblastoma growth.
Аннотация
Retinoblastoma (RB) remains a predominant intraocular malignancy in the pediatric population, and its clinical management is significantly impeded by limited blood-retinal barrier (BRB) penetration, the development of multidrug resistance, and severe systemic toxicity. This study aims to develop a novel nanodelivery system based on Zeolitic Imidazolate Framework-8 (ZIF-8) to overcome the limited bioavailability of the antiparasitic drug nitazoxanide (NTZ), and to enhance its anti-retinoblastoma efficacy. We successfully engineered ZIF-8@NTZ nanoparticles characterized by a robust core-shell architecture. Characterization results showed that the particles exhibited high drug loading capacity (approximately 58.628%), suitable particle size (∼231 nm), and significant pH-responsive drug release properties. In vitro assays indicated that ZIF-8@NTZ exerted potent inhibition on RB cell proliferation and induced apoptosis. In vivo experiments further confirmed that ZIF-8@NTZ could significantly inhibit tumor growth. This study indicates that the ZIF-8@NTZ nanosystem provides a promising strategy for the targeted therapy of retinoblastoma.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.